ClinicalTrials.gg
CompletedNCT02735434Updated Apr 30, 2021

Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety

An interventional study of Internet-based ACT and Internet-based discussion forum in Hypochondriasis, sponsored by University of Aarhus. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-30.

Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
101
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Health anxiety is a prevalent, disabling disorder associated with extensive health care expenditures. The lack of easily accessible, evidence-based psychological treatment combined with delayed diagnostic recognition constitute barriers to receiving treatment.

Aim

  1. To develop an internet-delivered treatment program, based on 'Acceptance and Commitment Therapy' (ACT), for patients with health anxiety.
  2. To test the feasibility and effectiveness of the treatment programme in a randomized, controlled trial, comparing the treatment with an active control condition.

Methods 150 patients aged 18 years and older can self-refer through a web-page to apply for participation. Before inclusion patients will undergo a video-diagnostic interview. Patients are randomly assigned to 12 weeks of either, 1) active treatment: consisting of internet-based ACT (iACT) with 7 therapist-guided modules of self-help text, exercises, patient videos and audio-files, or 2) active control condition: consisting of an internet-based discussion forum (iFORUM) with 7 topics of discussion.

All patients will complete self-report questionnaires at baseline, before randomization, at 4 and 8 weeks into treatment, after end of treatment, and at 6-month follow-up.

Read the detailed description

Severe health anxiety (illness anxiety disorder) or hypochondriasis, according to the psychiatric classification system ICD-10, is characterized by preoccupation with fear of having a serious illness, which interferes with daily functions and persists despite medical reassurance. Clinical significant health anxiety is prevalent in primary care with 0.8-9.5%, and has a lifetime prevalence of 5.7% in the general population. It is a disabling disorder, associated with extensive use of health care services and occupational disability.

Earlier, health anxiety has been considered a chronic disease with poor treatment outcomes. A recent review found effect of both medicine and psychotherapy, but patients may prefer psychotherapeutic treatments. Despite the high prevalence, health anxiety is rarely diagnosed within primary care, and there is limited access to evidence-based treatment for health anxiety.

An easily accessible, evidence-based treatment is needed for this debilitating condition.

Internet-based treatment is a new approach where patients receive access to a guided self-help program. A meta-analysis has shown equal treatment effects of internet-based treatment compared to "face-to-face" treatment for depressive- and anxiety disorders. Internet-based cognitive behavioral therapy for health anxiety has shown to be cost-effective. ACT is a new effective generation of cognitive-behavioral therapy, with an emphasis on acceptance and value-based exposure that has shown good results for treating health anxiety in a group setting. Internet-based Cognitive behavioral therapy (CBT) for health anxiety has shown promising results but low treatment completion. This may be due to the comprehensive treatment modules and the text-based format. ACT is an experiential behavioral therapy, and aims to activate patients with exercises, videos, audio-files and less text material.

Most persons with health anxiety have high health care expenditure. However, some patients with health anxiety avoid contact to the health care system, and may not receive proper treatment. Patient self-referral is a new approach that may facilitate access to treatment.

Aim

  1. To develop an internet-delivered treatment program for patients suffering from health anxiety based on ACT.
  2. To test the feasibility and effectiveness of the treatment programme in a randomized, controlled trial, comparing treatment with an active control condition.

Hypothesis Primary hypothesis Patients with health anxiety treated with iACT will at 6-month follow-up report a significant reduction in illness worry compared to the action control condition iFORUM.

Secondary hypotheses

Patients with health anxiety treated with iACT compared to the active control condition iFORUM will at 6-month follow-up report:

  1. a reduction in physical symptoms and symptoms of anxiety and depression
  2. increased health-related quality of life
  3. more expedient illness perceptions and increased acceptance of symptoms

    Mediation analyses

  4. changes in illness perception and acceptance mediate the effect of iACT
02

Conditions studied

  • Hypochondriasis

Keywords

  • Health anxiety
  • illness anxiety disorder
  • ACT
  • internet
03

In context

Lead sponsor

University of Aarhus is the lead sponsor of 1,303 studies on the registry; 190 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Severe health anxiety > 6 months
  2. Whiteley-7 score (scale 0-100 score points) corresponding to 21,4 or more.
  3. Age above 18 years old
  4. In case of a comorbid functional or other psychiatric disorder health anxiety must be the dominant problem
  5. Patients who speak, read and write Danish
  6. Access to a computer and internet access
  7. Residence in Denmark

Exclusion criteria

Exclusion criteria:

  1. Acute suicidal risk
  2. Abuse of narcotics or alcohol and (non-prescribed) medicine
  3. Lifetime-diagnosis of psychoses, bipolar affective disorder or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.3, F33.3)
  4. Pregnancy
  5. Unstable psychopharmacological treatment within last 2 months
  6. Former treatment at the Research Clinic for Functional Disorders and Psychosomatics
  7. Not providing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
101 participants (actual)

Study arms

  • Experimental
    Internet-based ACT

    Brief clinical psychiatric assessment to determine eligibility (video-based).

    Behavioral: Internet-based ACT

  • Active comparator
    Internet-based discussion forum

    Brief clinical psychiatric assessment to determine eligibility (video-based).

    Other: Internet-based discussion forum

Interventions

  • BehavioralInternet-based ACT

    The guided internet program consists of 7 modules activated consecutively over a period of 12 weeks. The content is written psycho education, patient videos, audio-exercises and behavioural exposure exercises. The program is therapist-guided; hence all patients will receive support from primarily the same therapist during the 12 weeks.

  • OtherInternet-based discussion forum

    The online discussion forum consists of 7 themes touching upon the impact of health anxiety and the patients own coping strategies. The themes are activated consecutively over a period of 12 weeks. The discussion forum is text-based, and only patients will participate in the discussion. The written discussions will be reviewed by a professional for ethical reasons. The discussion forum aims to control for the effect of attention and contacts to the health care system. After 9 months patients in the discussion forum are offered active treatment, but not as part of the research project.

06

What researchers measure

Primary outcomes

  1. Whiteley-7 index

    Health anxiety symptoms

    Time frame: At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

Secondary outcomes

  1. Demographic questions measured with questions from the Danish study for Functional Disorders (DanFund)

    Time frame: At baseline (i.e. at self-referral)

  2. Diagnosed somatic illnesses measured with questions from the Danish study for Functional Disorders (DanFund)

    Time frame: At baseline (i.e. at self-referral)

  3. Quality of life measured with the World Health Organisation Well-being Index-Five (WHO-5)

    Time frame: At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

  4. Quality of life measured with the visual analogue scale (VAS question) from Youth profile, National Institute of Public Health

    Time frame: At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

  5. Stress measured with questions from the survey Youth stress, Danish Health Authority

    Time frame: At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

  6. Health anxiety symptoms measured with the Short Health Anxiety Inventory (SHAI)

    Time frame: At baseline (i.e. at self-referral), and 3 and 9 months after randomisation

  7. Anxiety, depression, obsessive-compulsive and physical symptoms measured with subscales from the Symptom Checklist (SCL-92)

    Time frame: At baseline (i.e. at self-referral), and 3 and 9 months after randomisation

  8. Somatisation measured with the Bodily Distress Syndrome Checklist (BDS Checklist)

    Time frame: At baseline (i.e. at self-referral)

  9. General health status and functioning measured with the Short Form 12 Health Survey (SF-12)

    Time frame: At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline), 3 and 9 months after randomisation

Other outcomes

  1. Psychological flexibility measured with the Acceptance and Action Questionnaire-II (AAQ-II)

    Time frame: At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  2. Non-reactivity measured with a subscale of the Five Facet Mindfulness Questionnaire (FFMQ)

    Time frame: At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  3. Illness perception measured with the Brief Illness Perception Questionnaire (B-IPQ)

    Time frame: At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  4. Personality traits measured with the short version of the Big Five Inventory (BFI-10)

    Time frame: Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)

  5. Working alliance measured with the Working Alliance Inventory, Patient version (WAI-pt)

    Time frame: 2 weeks into treatment, and 3 months after randomisation

  6. Treatment credibility and expectancy measured with the credibility/ expectancy questionnaire

    Time frame: Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)

  7. Childhood history questionnaire

    Time frame: Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)

  8. Traumatic events in childhood measured with the Childhood traumatic event scale

    Time frame: Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)

  9. Attachment style measured with the questionnaire: Experiences in close relationships - relationship structures (ECR-RS)

    Time frame: Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)

  10. Treatment evaluation of negative effects measured with the Inventory for the assessment of negative effects of psychotherapy (INEP)

    Time frame: 9 months after randomisation

  11. Attitudes toward seeking professional help

    Time frame: At baseline (i.e. at self-referral) and at 3 months after randomisation

  12. Self-reported health care use, work performance and work absence measured with Trimbos/ institute of Health Policy and Management (iMTA) questionnaire for Costs associated with Psychiatric Illness (TiC-P)

    Time frame: At baseline (i.e. at self-referral) and at 9 months after randomisation

  13. Health care expenditures extracted from Danish national registers, and degree of illness related absence from work extracted from the Danish Register of Sickness absence compensation benefits and Social transfer payments database (DREAM).

    Time frame: At baseline (i.e. at self-referral) and at 9 months after randomisation

  14. Health literacy measured with the Health Literacy Questionnaire (HLQ)

    Time frame: At baseline (i.e. at self-referral)

  15. Values measured with the Sources of Meaning and Meaning in life questionnaire (SoMe-26)

    Time frame: At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  16. Negative events and effects of psychological treatment

    Time frame: At 3 months after randomisation

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Risor BW, Frydendal DH, Villemoes MK, Nielsen CP, Rask CU, Frostholm L. Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial. Pharmacoecon Open. 2022 Mar;6(2):179-192. doi: 10.1007/s41669-021-00319-x. Epub 2022 Jan 8. PubMed 34997899 ↗
  • Hoffmann D, Rask CU, Hedman-Lagerlof E, Jensen JS, Frostholm L. Efficacy of internet-delivered acceptance and commitment therapy for severe health anxiety: results from a randomized, controlled trial. Psychol Med. 2021 Nov;51(15):2685-2695. doi: 10.1017/S0033291720001312. Epub 2020 May 14. PubMed 32404226 ↗
  • Hoffmann D, Rask CU, Hedman-Lagerlof E, Eilenberg T, Frostholm L. Accuracy of self-referral in health anxiety: comparison of patients self-referring to internet-delivered treatment versus patients clinician-referred to face-to-face treatment. BJPsych Open. 2019 Sep 9;5(5):e80. doi: 10.1192/bjo.2019.54. PubMed 31496462 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2016 to primary completion in Apr 2017, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2016
First posted
Apr 12, 2016
StartActual
Apr 2016
Primary completionActual
Apr 2017
CompletionActual
Mar 2018
Last update
Apr 30, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02735434
Responsible party
Sponsor
First posted
Apr 12, 2016
Start date
Apr 2016
Primary completion
Apr 2017
Completion
Mar 2018
Last update
Apr 30, 2021

Study contacts

Lisbeth Frostholm, PhD
principal investigator · Aarhus University Hospital
Charlotte U Rask, PhD
principal investigator · Aarhus University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion